AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Inhibikase Therapeutics, Inc.
$1.55
-$0.40 (-20.51%)
Previous Close
$1.67
Day Range
$1.52$1.67
Year Range
$1.33$2.61
Market Cap
216.28M
AVG Volume
723.39K
Trailing/Forward PE
-3.26/-
PEG ratio
0.25
Dividend Yield
-
Next Earnings Date
2026-11-13
Primary Exchange
NASDAQ
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: IKT
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 13 Nov 2026.
Video analysis: IKT
All videosNo video analysis for this stock yet. Request one from our team.
